On this page
Asparlas
calaspargase pegol-mknl
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Asparlas
Proper name
calaspargase pegol-mknl
Licence type
351(a)
BLA number
761102
Applicant
Servier Pharmaceuticals LLC
Center
CDER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 3,750UNITS/5ML (750UNITS/ML) | Injection | Intravenous | Single-Dose Vial | Rx | December 20, 2018 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | February 1, 2001 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |